1. Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM. (3rd October 2022) Authors: Steytler, John; van der Ryst, Elna; Craig, Charles; Van Baelen, Ben; Nuttall, Jeremy; van Niekerk, Neliëtte; Mellors, John; Parikh, Urvi; Wallis, Carole Journal: Clinical infectious diseases Issue: Volume 76:Number 3(2023) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial. Issue 5 (September 2014) Authors: DeJesus, Edwin; Fätkenheuer, Gerd; Orrell, Catherine; Wang, Cunshan; Jones, James; Craig, Charles; Tawadrous, Margaret; Heera, Jayvant Journal: HIV clinical trials Issue: Volume 15:Issue 5(2014) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials. (December 2019) Authors: Jubb, Becky; Lewis, Marilyn; McFadyen, Lynn; Simpson, Paul; Mori, Julie; Chan, Phylinda; Weatherley, Barry; van der Ryst, Elna; Westby, Mike; Craig, Charles Journal: Antiviral chemistry & chemotherapy Issue: Volume 27(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment. (15th May 2016) Authors: Stellbrink, Hans-Jürgen; Le Fevre, Eric; Carr, Andrew; Saag, Michael S.; Mukwaya, Geoffrey; Nozza, Silvia; Valluri, Srinivas Rao; Vourvahis, Manoli; Rinehart, Alex R.; McFadyen, Lynn; Fichtenbaum, Carl; Clark, Andrew; Craig, Charles; Fang, Annie F.; Heera, Jayvant Journal: AIDS Issue: Volume 30:Number 8(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment. (15th May 2016) Authors: Stellbrink, Hans-Jürgen; Le Fevre, Eric; Carr, Andrew; Saag, Michael S.; Mukwaya, Geoffrey; Nozza, Silvia; Valluri, Srinivas Rao; Vourvahis, Manoli; Rinehart, Alex R.; McFadyen, Lynn; Fichtenbaum, Carl; Clark, Andrew; Craig, Charles; Fang, Annie F.; Heera, Jayvant Journal: AIDS Issue: Volume 30:Number 8(2016) Page Start: 1229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1. Issue 5 (May 2018) Authors: Giaquinto, Carlo; Mawela, Muthuhadini Patience; Chokephaibulkit, Kulkanya; Negra, Marinella Della; Mitha, Ismail Haroon; Fourie, Jan; Fang, Annie; van der Ryst, Elna; Valluri, Srinivas Rao; Vourvahis, Manoli; Zhang-Roper, Rebecca Yanhui; Craig, Charles; McFadyen, Lynn; Clark, Andrew; Heera, Jayvant Journal: Pediatric infectious disease journal Issue: Volume 37:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. Issue 2 (February 2021) Authors: Nel, Annalene; van Niekerk, Neliëtte; Van Baelen, Ben; Malherbe, Mariëtte; Mans, Winél; Carter, Allison; Steytler, John; van der Ryst, Elna; Craig, Charles; Louw, Cheryl; Gwetu, Thando; Mabude, Zonke; Kotze, Philip; Moraba, Robert; Tempelman, Hugo; Gill, Katherine; Kusemererwa, Sylvia; Bekker, Li... Journal: Lancet Issue: Volume 8:Issue 2(2021) Page Start: e77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The maraviroc expanded access program — safety and efficacy data from an open-label study. Issue 1 (February 2015) Authors: Lazzarin, Adriano; Reynes, Jacques; Molina, Jean-Michel; Valluri, Srinivas; Mukwaya, Geoffrey; Heera, Jayvant; Craig, Charles; van der Ryst, Elna; Sierra-Madero, Juan G. Journal: HIV clinical trials Issue: Volume 16:Issue 1(2015) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗